Related Experiment Videos
Fibronectin: applications to clinical medicine
Critical Reviews in Clinical Laboratory Sciences
|January 1, 1986
Summary
The clinical use of fibronectin is uncertain, requiring more research. While potentially beneficial for septic patients, its efficacy and safety need validation through controlled human trials.
Area of Science:
- Biochemistry
- Clinical Medicine
- Immunology
Background:
- Fibronectin's role in sepsis and organ failure is debated.
- Current data on fibronectin therapy efficacy is limited.
- Transfusion-transmitted disease risks necessitate careful evaluation.
Purpose of the Study:
- To assess the current evidence for fibronectin's clinical utility.
- To highlight the need for controlled clinical trials.
- To determine the potential patient population for fibronectin therapy.
Main Methods:
- Review of existing literature on fibronectin in clinical settings.
- Analysis of correlations between fibronectin levels, sepsis, and organ failure.
- Identification of data gaps regarding fibronectin therapy efficacy and safety.
Main Results:
- No controlled trials using purified fibronectin have been reported.
- Correlation between sepsis/organ failure and decreased fibronectin levels remains questionable.
- Clinical efficacy data to balance transfusion risks is lacking.
Conclusions:
- Fibronectin's clinical role is not yet established.
- Controlled human studies are essential for definitive conclusions.
- Potential benefits are likely limited to septic and critically ill patients.